Epidermal basaloid proliferation in cutaneous myxomas

Journal of Cutaneous Pathology

Volumn 30, Issue 8, 2003, Pages 499-503

  Mehregan, Darius R ^a   Thomas, Laura ^b   Thomas, Jean E ^a  

^a Pinkus Dermatopathology Laboratory   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; EOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HEMATOXYLIN; PROTEIN P53;

ADULT; AGED; ARTICLE; BASAL CELL; BASAL CELL CARCINOMA; BENIGN TUMOR; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITOSIS; MYXOMA;

ADULT; AGED; CARCINOMA, BASAL CELL; CELL DIVISION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYXOMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0141520332     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2003.00101.x     Document Type: Article

References (17)

1. Alaiti S, Nelson FP, Ryoo JW. Solitary cutaneous myxoma. J Am Acad Dermatol 2000; 43: 377.
2. Carney JA, Headington JT, Su WPD. Cutaneous myxomas: a major component of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Arch Dermatol 1986; 122: 790.
3. Richard O. Myxomas. In Andrews' diseases of the skin. Philadelphia: W.B. Saunders, 2000; 777.
4. Carney JA, Gordon H, Carpenter PC, Shenoy BC, Go VLW. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985; 64: 270.
5. Allen PW, Dymock RB, MacCormac LB. Superficial angiomyxomas with and without epithelial components. Am J Surg Pathol 1988; 12 (7): 519.
6. Ferreiro JA, Carney JA. Myxomas of the external ear and their significance. Am J Surg Pathol 1994; 18 (3): 274.
7. Calonje E, Guerin D, McCormick D, Fletcher CDM. Superficial angiomyxoma. Clinicopathologic analysis of a series of distinctive but poorly recognized cutaneous tumors with tendency for recurrence. Am J Surg Pathol 1999; 23 (8): 910.
8. Morgan MB, Howard HG, Everett MA. Epithelial induction in dermatofibroma: a role for epidermal growth factor (EGF) receptor. Am J Dermatopathol 1997; 19 (1): 35.
9. Histiocytoma. Pinkus's guide to dermatohistopathology, 6th ed. Norwalk, CT: Appleton & Lange, 1995; 357.
10. Rossen K, Haerslev T, Hou-Jensen K, Krag Jacobsen G. Metallothionein expression in basaloid proliferation overlying dermatofibromas and in basal cell carcinomas. Br J Dermatol 1997; 136: 30.
11. DeRosa G, Staibano S, Barra E, et al. p53 protein in aggressive and nonaggressive basal cell carcinoma. J Cutan Pathol 1993; 20: 429.
12. Haersley T, Rossen K, Hou-Jensen K, Krag Jacobons G. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas. Acta Derm Venereol Suppl (Stockh) 1995; 75: 187.
13. Barrett TL, Smith KJ, Hodge JJ, Butler R, Hall FW, Skelton HG. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma. J Am Acad Dermatol 1997; 37: 430.
14. Boulougouris P, Elder J. Epidermal growth factor receptor structure, regulation, mitogenic signalling effects activation. Anticancer Res 2001; 21: 2769.
15. Krahn G, Leiter U, Kaskel P, et al. Coexpression patterns of EGFR, HER2, HER3, and HER4 in non-melanoma skin cancer. Eur J Cancer 2001; 37 (2): 251.
16. Han KH, Huh CH, Cho KH. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma immunohistochemical characterization. Am J Dermatopathol 2001; 23 (2); 90.
17. Rahbari H, Mehregan AH. Adnexal displacement and regression in association with histiocytoma (dermatofibroma). J Cutan Pathol 1985; 12: 94.